Israeli researchers lead a study to predict the success of personalized immunotherapy, avoiding biopsies and conventional cancer treatment.
Graph, from left: The testing process up to the decision if immunotherapy treatment is suitable for the patient.(photo credit: TECHNION)ByJUDY SIEGEL-ITZKOVICHUpdated:
